291 related articles for article (PubMed ID: 9138526)
1. Paul Ehrlich: pathfinder in cell biology. 1. Chronicle of his life and accomplishments in immunology, cancer research, and chemotherapy.
Kasten FH
Biotech Histochem; 1996 Jan; 71(1):2-37. PubMed ID: 9138526
[TBL] [Abstract][Full Text] [Related]
2. Paul Ehrlich: the Nobel Prize in physiology or medicine 1908.
Piro A; Tagarelli A; Tagarelli G; Lagonia P; Quattrone A
Int Rev Immunol; 2008; 27(1-2):1-17. PubMed ID: 18300053
[TBL] [Abstract][Full Text] [Related]
3. [Famous German physician and researcher Paul Ehrlich and his role in the development of immunology and chemotherapy (to his 150-year birthday anniversary)].
Pavlovskiĭ LN
Lik Sprava; 2004 Dec; (8):93-8. PubMed ID: 15771082
[TBL] [Abstract][Full Text] [Related]
4. Paul Ehrlich--in search of the magic bullet.
Winau F; Westphal O; Winau R
Microbes Infect; 2004 Jul; 6(8):786-9. PubMed ID: 15207826
[TBL] [Abstract][Full Text] [Related]
5. Paul Ehrlich: pioneer of chemotherapy and cure by arsenic (1854-1915).
Thorburn AL
Br J Vener Dis; 1983 Dec; 59(6):404-5. PubMed ID: 6196079
[TBL] [Abstract][Full Text] [Related]
6. The contributions of Paul Ehrlich to infectious disease.
Gensini GF; Conti AA; Lippi D
J Infect; 2007 Mar; 54(3):221-4. PubMed ID: 16567000
[TBL] [Abstract][Full Text] [Related]
7. [Letters from the Nobellaureter Paul Ehrlich to the Director for the State Serum Institute in Copenhagen, Thorvald Madsen].
Kristiansen JE; Hendricks O; Permin H
Dan Medicinhist Arbog; 2004; ():173-91. PubMed ID: 15685791
[TBL] [Abstract][Full Text] [Related]
8. The return of Ehrlich's 'Therapia magna sterilisans' and other Ehrlich concepts?. Series of papers honoring Paul Ehrlich on the occasion of his 150th birthday.
Sörgel F
Chemotherapy; 2004 Apr; 50(1):6-10. PubMed ID: 15084798
[TBL] [Abstract][Full Text] [Related]
9. Paul Ehrlich's passion: the origins of his receptor immunology.
Silverstein AM
Cell Immunol; 1999 Jun; 194(2):213-21. PubMed ID: 10383824
[TBL] [Abstract][Full Text] [Related]
10. Paul Ehrlich and the Early History of Granulocytes.
Kay AB
Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726791
[TBL] [Abstract][Full Text] [Related]
11. [The marksman of medicine, Paul Ehrlich (1854-1915)].
Kiss L
Orv Hetil; 2005 Jul; 146(28):1499-502. PubMed ID: 16130446
[No Abstract] [Full Text] [Related]
12. [Paul Ehrlich (1854-1914), pioneer in immunology and chemotherapy. In memory of his 75th birthday].
Köhler W
Z Arztl Fortbild (Jena); 1991 Jan; 85(1-2):87-92. PubMed ID: 2028665
[No Abstract] [Full Text] [Related]
13. [Ilya Ilich Metchnikov and Paul Ehrlich: 1908 Nobel Prize winners for their research on immunity].
Lokaj J; John C
Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):119-24. PubMed ID: 19069024
[TBL] [Abstract][Full Text] [Related]
14. [Paul Ehrlich (1854-1915) and his contacts with East European physicians at the time of testing the first chemioterapeutics].
Schneck P
Arch Hist Filoz Med; 1996; 59(1):41-8. PubMed ID: 11619177
[TBL] [Abstract][Full Text] [Related]
15. Paul Ehrlich (1854-1915): founder of chemotherapy and pioneer of haematology, immunology and oncology.
Androutsos G
J BUON; 2004; 9(4):485-91. PubMed ID: 17415859
[TBL] [Abstract][Full Text] [Related]
16. Elie Metchnikoff's and Paul Ehrlich's impact on infection biology.
Kaufmann SH
Microbes Infect; 2008; 10(14-15):1417-9. PubMed ID: 18824243
[TBL] [Abstract][Full Text] [Related]
17. Ilya Ilich Metchnikoff (1845-1915) and Paul Ehrlich (1854-1915): the centennial of the 1908 Nobel Prize in Physiology or Medicine.
Schmalstieg FC; Goldman AS
J Med Biogr; 2008 May; 16(2):96-103. PubMed ID: 18463079
[TBL] [Abstract][Full Text] [Related]
18. The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize.
Bosch F; Rosich L
Pharmacology; 2008; 82(3):171-9. PubMed ID: 18679046
[TBL] [Abstract][Full Text] [Related]
19. [Origins of chemotherapy (Paul Ehrlich)].
Kempler K
Orv Hetil; 1979 May; 120(20):1203-6. PubMed ID: 377188
[No Abstract] [Full Text] [Related]
20. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
Høilund-Carlsen PF
Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
